Abstract:BackgroundThe treatments currently approved for Duchenne muscular dystrophy (DMD), a progressive skeletal muscle wasting disease, address the needs of only a small proportion of patients resulting in an urgent need for therapies that benefit all patients regardless of the underlying mutation. Myostatin is a member of the transforming growth factor-β (TGF-β) family of ligands and is a negative regulator of skeletal muscle mass. Loss of myostatin has been shown to increase muscle mass and improve muscle function in both normal and dystrophic mice. Therefore, myostatin blockade via a specific antibody could ameliorate the muscle weakness in DMD patients by increasing skeletal muscle mass and function, thereby reducing patients’ functional decline.MethodsA murine anti-myostatin antibody, mRK35, and its humanized analog, domagrozumab, were developed and their ability to inhibit several TGB-β ligands was measured using a cell-based Smad-activity reporter system. Normal and mdx mice were treated with mRK35 to examine the antibody’s effect on body weight, lean mass, muscle weights, grip strength, ex vivo force production, and fiber size. The humanized analog (domagrozumab) was tested in non-human primates (NHPs) for changes in skeletal muscle mass and volume as well as target engagement via modulation of circulating myostatin.ResultsBoth the murine and human antibodies are specific and potent inhibitors of myostatin and GDF11. mRK35 is able to increase body weight, lean mass, and muscle weights in normal mice. In mdx mice, mRK35 significantly increased body weight, muscle weights, grip strength, and ex vivo force production in the extensor digitorum longus (EDL) muscle. Further, tibialis anterior (TA) fiber size was significantly increased. NHPs treated with domagrozumab demonstrated a dose-dependent increase in lean mass and muscle volume and exhibited increased circulating levels of myostatin demonstrating target engagement.ConclusionsWe demonstrated that the potent anti-myostatin antibody mRK35 and its clinical analog, domagrozumab, were able to induce muscle anabolic activity in both rodents, including the mdx mouse model of DMD, and non-human primates. A Phase 2, potentially registrational, clinical study with domagrozumab in DMD patients is currently underway.

A Novel Nanobody Directed Against Ovine Myostatin to Enhance Muscle Growth in Mouse

Inhibition of myostatin in adult mice increases skeletal muscle mass and strength

Knockdown of Endogenous Myostatin Promotes Sheep Myoblast Proliferation.

Novel myostatin-specific antibody enhances muscle strength in muscle disease models

Administration of a Mutated Myostatin Propeptide to Neonatal Mice Significantly Enhances Skeletal Muscle Growth

The critical role of myostatin in differentiation of sheep myoblasts.

Proteomic Studies on the Mechanism of Myostatin Regulating Cattle Skeletal Muscle Development

Effect of MSTN Propeptide and Shrna Co-expression Vector on Proliferation of Skeletal Muscle Satellite Cells

Research Progress on Myostatin

An integrated analysis of mRNA and miRNA in skeletal muscle from myostatin-edited Meishan pigs

Myostatin Gene Targeting in Cultured China Han Ovine Myoblast Cells

Functional verification of a porcine myostatin propeptide mutant

A mouse anti-myostatin antibody increases muscle mass and improves muscle strength and contractility in the mdx mouse model of Duchenne muscular dystrophy and its humanized equivalent, domagrozumab (PF-06252616), increases muscle volume in cynomolgus monkeys

Knockout of Myostatin by Zinc-finger Nuclease in Sheep Fibroblasts and Embryos.

Oral administration of myostatin-specific whole recombinant yeast Saccharomyces cerevisiae vaccine increases body weight and muscle composition in mice.

Novel Pro-myogenic Factor Neoruscogenin Induces Muscle Fiber Hypertrophy by Inhibiting MSTN Maturation and Activating the Akt/mTOR Pathway

HMEJ-mediated site-specific integration of a myostatin inhibitor increases skeletal muscle mass in porcine

Muscle-specific transgenic expression of porcine myostatin propeptide enhances muscle growth in mice

Efficient Generation of Myostatin (MSTN) Biallelic Mutations in Cattle Using Zinc Finger Nucleases.

Immunization of Mother Mice with Recombinant Myostatin C-domain Increasing the Body Weight of Neonatal Mice

Mutation in myostatin 3'UTR promotes C2C12 myoblast proliferation and differentiation by blocking the translation of MSTN